Ingalls & Snyder LLC’s Biogen BIIB Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q4 | – | Sell |
-740
| Closed | -$209K | – | 446 |
|
|
2021
Q3 | $209K | Buy |
740
+90
| +14% | +$25.4K | 0.01% | 408 |
|
|
2021
Q2 | $225K | Sell |
650
-70
| -10% | -$24.2K | 0.01% | 402 |
|
|
2021
Q1 | $201K | Buy |
+720
| New | +$201K | 0.01% | 397 |
|
|
2020
Q1 | – | Sell |
-735
| Closed | -$218K | – | 393 |
|
|
2019
Q4 | $218K | Sell |
735
-140
| -16% | -$41.5K | 0.01% | 353 |
|
|
2019
Q3 | $204K | Sell |
875
-5,789
| -87% | -$1.35M | 0.01% | 388 |
|
|
2019
Q2 | $1.56M | Sell |
6,664
-5,381
| -45% | -$1.26M | 0.08% | 175 |
|
|
2019
Q1 | $2.85M | Buy |
12,045
+4,608
| +62% | +$1.09M | 0.14% | 127 |
|
|
2018
Q4 | $2.24M | Sell |
7,437
-303
| -4% | -$91.2K | 0.12% | 136 |
|
|
2018
Q3 | $2.74M | Sell |
7,740
-59
| -0.8% | -$20.8K | 0.12% | 141 |
|
|
2018
Q2 | $2.26M | Sell |
7,799
-390
| -5% | -$113K | 0.11% | 139 |
|
|
2018
Q1 | $2.24M | Buy |
8,189
+1,521
| +23% | +$416K | 0.11% | 140 |
|
|
2017
Q4 | $2.12M | Buy |
6,668
+491
| +8% | +$156K | 0.1% | 146 |
|
|
2017
Q3 | $1.93M | Buy |
6,177
+3
| +0% | +$939 | 0.1% | 137 |
|
|
2017
Q2 | $1.68M | Buy |
6,174
+133
| +2% | +$36.1K | 0.09% | 144 |
|
|
2017
Q1 | $1.65M | Buy |
6,041
+3,397
| +128% | +$929K | 0.09% | 158 |
|
|
2016
Q4 | $750K | Sell |
2,644
-97
| -4% | -$27.5K | 0.04% | 213 |
|
|
2016
Q3 | $858K | Buy |
2,741
+36
| +1% | +$11.3K | 0.05% | 200 |
|
|
2016
Q2 | $654K | Buy |
2,705
+625
| +30% | +$151K | 0.04% | 220 |
|
|
2016
Q1 | $541K | Buy |
2,080
+61
| +3% | +$15.9K | 0.03% | 221 |
|
|
2015
Q4 | $618K | Sell |
2,019
-104
| -5% | -$31.8K | 0.04% | 214 |
|
|
2015
Q3 | $619K | Buy |
+2,123
| New | +$619K | 0.04% | 206 |
|